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INTRODUCTION
Osteoclasts are the primary cells responsible for
bone resorption. They arise by the differentiation
of osteoclast precursors of the monocyte/macrophage
lineage. These cells are required not only for the
development of the skeleton but also for mineral
homeostasis and normal remodeling of bone in adult
animals (1, 2). Bone resorption depends on the ability
of the osteoclast to generate an acid extracellular
compartment between itself and the bone surface
(3). Increased osteoclastic resorption and subsequent
bone loss are common features of many debilitating
diseases including osteoporosis, bone metastases,
Paget’s disease, and rheumatoid arthritis. Local
factors produced by stromal cells or osteoblastic
cells in the bone microenvironment play an important
role in osteoclast differentiation. Recent evidence
supports a central role for tumor necrosis factor
gene family members receptor activator of nuclear
factor κB (RANK) ligand and RANK receptor in
osteoclast differentiation (4).
Serotonin transporters (SERTs) are pre-synaptic
proteins specialized for the clearance of serotonin
following vesicular release at central nervous system
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(CNS) and enteric nervous system synapses (5) . SERT
are also expressed on a number of specialized,
non-neural cells, including platelets, and placental
(5). SERT are high affinity targets in vivo for anti-
depressants such as serotonin selective reuptake
inhibitors (SSRIs) and Hypericum perforatum L
(St John’s wort) (6). The functions of SSRIs are
believed to exert at least a portion of their physi-
ologic actions by elevating extracellular serotonin
concentrations and extending the duration, and spatial
spread of serotonin signals (7). The inhibitory effects
of anti-depressants on SERT activity are considered
to be linked with the phosphorylation of SERT (8).
SSRIs may facilitate protein kinase C-mediated
phosphorylation and sequential internalization of
SERT by stopping the transport of substrate
through SERT. However, these studies are made
difficult by the lack of an appropriate in vitro
model. In this study, we investigated the regula-
tion of serotonin reuptake by food factors in osteo-
clasts system.
MATERIALS AND METHODS
Three constituents (hyperforin, hypericin and
amentoflavone) were obtained from EMD Bi-
osciences, Inc. (CA, USA), BIOMOL Research
Laboratories Inc. (PA, USA) and Extrasynthese
(Genay, France) . Osteoclasts were generated from
mouse monocyte/macrophage cell line RAW 264.7
cells and mouse bone marrow cells as described
previously (9). The medium was refreshed on day
3, and osteoclast formation was assayed by counting
the number of TRAP-positive cells per well between
days 7 and 10. RT-PCR was generated using the




was used as control for success of the RT-PCR
reaction (9).
Serotonin transport was studied in monolayers
of RANKL-differentiated RAW 264.7 cells (9). The
measurement of serotonin transport was performed
using a modification of a previously described
procedure (10, 11). Briefly, RAW264.7 cells were plated
in 12-well plates at a density of 5×103/cm2 and cultured
for 7 days with or without recombinant RANKL
(320 ng/ml) in α-MEM without phenol-red supple-
mented with 10% charcoal-stripped fetal bovine
serum. Cells were washed twice with KRH (120 mM
NaCl, 4.7 mM KCl, 2.2 mM CaCl2, 10 mM HEPES,
1.2 mM KH2PO4, 1.2 mM MgSO4) and incubated
in KRH with 1.8g/l D-glucose for 10 min. Inhibitors
were added in the preincubation steps. Cells were
incubated with the indicated concentrations of 10 nM
[3H] serotonin(～100 Ci/mmol ; Amersham Phar-
macia Biotech, Piscataway, NJ, USA) containing
100 μM pargyline and 100 μML-ascorbic acid with or
without inhibitors for 10 minutes at 37. Incubation
was terminated with three washes of ice-cold KRH.
The accumulated [3H] serotonin was determined
by solubilizing the cells with 250 μl 0.1 N NaOH
and liquid scintillation spectrometry. Serotonin transport
activity was calculated as nanomoles of per mg protein
taken up in 10 min or plotted as a percentage of
specific serotonin uptake obtained in the absence
of inhibitors.
RESULTS AND DISCUSSION
To characterize the osteoclast-like cells, we first
performed a histochemical analysis of RANKL-
treated RAW 264.7 cells. After seven days of treat-
ment of RANKL, the multinucleated cells were
markedly increased compared with cells treated
for 24h (Fig. 1A). Using gene microarray, we found
that mouse SERT was strongly expressed in
RANKL-induced osteoclast-like cells (data not shown).
The expression was also indicated by RT-PCR in
osteoclast derived from RAW 264.7 or mouse bone
marrow cells (Fig. 1B). In RANKL stimulation of RAW
264.7 cells, the serotonin uptake was strongly
upregulated in RANKL-induced cells (Fig. 2 A) . The
SSRIs, fluoxetine and fluvoxamine markedly inhibits
the serotonin transport activity at concentrations
of～1μM (Fig. 2A). To further investigate the effects
of extracts of St John’s wort on SERT activity, [3H]
-serotonin uptake was measured in this system
(Fig. 2B). Hyperforin and hypericine that inhibited
brain synaptosomal serotonin uptake were also
significantly decreased in transport activity. Thus,
a new in vitro model using RANKL-induced osteoclast
-like cells may be useful to analyze the regulation
of SERT by food factors and SSRIs.
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Figure 2. Effects of SSRIs and extracts of St John’s wort in osteoclast. (A) RAW 264.7 cells were cultured in the presence or
absence of RANKL. The cells were preincubated for 15 min, and then the uptake was assayed with 10 nM [3H]-serotonin. The
inhibitors were added in preincubation and uptake steps. *p<0.05.Values are reported as means±S.E. (B) Effects of extracts of St
John’s wort. The grey bar is indicated 1 μM and stripe bar is 10 μM.
Figure 1. RANKL-induced osteoclastgenesis of macrophage-derived RAW 264.7 cells. (A) Differentiation of osteoclast-like cells
(24 h, 48 h, 96 h,and 7 days after treated of RANKL). (B) On day 7, the expression of serotonin transporter (SERT) was detected
by RT-PCR in RAW 264.7(RAW) or bone marrow cells (BMC) which is cultured in the presence or absence of RANKL.
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